NL-OMON27925
Suspended
Not Applicable
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low risk for recurrence
VALT oncology0 sites864 target enrollmentTBD
Conditionsnon-small-cell lung cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- non-small-cell lung cancer
- Sponsor
- VALT oncology
- Enrollment
- 864
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \>\= 18 years
- •2\. Patients with NSCLC, pT2N0, pT1N1, pT2N1, pT3N0 and pT3N1
Exclusion Criteria
- •1\. Patients with incomplete or inadequate pulmonary resections. incomplete preoperative or intraoperative staging, wedge or segmental resection.
- •2\. Prior chemotherapy or radical radiotherapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small-cell lung cancer patients with high-risk for recurrence: NVALT 8Bon-small-cell lung cancerNL-OMON24423MCGHanzeplein 19700 RB Groningen600
Active, not recruiting
Not Applicable
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low-risk for recurrence: NVALT-8A - NVALT-8AThis is a randomized multicenter phase III study. Patient with a low SUV of the primary tumor prior to surgery will be randomised to four cycles of cisplatin-based chemotherapy or observation in a non-inferiority design.EUCTR2007-002644-21-NLMCG
Completed
Phase 3
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small-cell lung cancer patients with high-risk for recurrence: NVALT- 8B.lung cancerNon-small cell lung cancer10038666NL-OMON35584niversitair Medisch Centrum Groningen600
Not yet recruiting
Phase 3
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low risk for recurrence: NVALT-8AlungcancerNon-smal cell lung cancer10038666NL-OMON34015niversitair Medisch Centrum Groningen864
Active, not recruiting
Not Applicable
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in patients with high risk for recurrence and completely resected non-small-cell lung cancer: NVALT-8B - NVALT-8BThis is a randomized multicenter phase III study. Patient with a high SUVof the primary tumor prior to surgery will be randomised to four cycles of pemetrexed and cisplatin with or without nadroparin for 16 weeks in order to improve the recurrence-free survival rate in these patients.EUCTR2007-002608-16-NLMCG